Variation of Inventory listing following evaluation — 15 June 2021
The Executive Director is varying the terms of the Inventory listing for the following chemical. An evaluation of the chemical reclassified it as a hazardous substance. The critical health effect of the chemical is developmental toxicity (impact on foetal development) following repeated exposure. This variation is to manage the risk to worker health. Our evaluation report published on 8 January 2021 outlines the Executive Director’s decision leading to this variation.
Ethanol, 2-[2-(2-methoxyethoxy)ethoxy]-, 1,1',1''-triester with boric acid (H3BO3)
|Updated specific information requirements||Obligations to provide information apply. You must tell us within 28 days if the circumstances of your importation or manufacture (introduction) are different to those in our evaluation.
|Variation date||14 July 2021|
- reassessed the chemical’s human health hazards.
- reassessed risks the chemical posed to workers and the public.
- considered a new developmental toxicity study that was not available when it was originally assessed under the Industrial Chemicals (Notification and Assessment) Act 1989 (the Act).
- identified a potential risk of developmental toxicity to workers associated with a change to the process as described in the report for handling or repackaging of brake fluids containing the chemical.
The Executive Director is varying the terms of the Inventory listing for the chemical in accordance with section 86 the Industrial Chemicals Act 2019 (IC Act).
If you have any questions, please contact us and use the topic ‘AICIS Evaluations’.